Andere talen Nuformix plc

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:35:06 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,185 ^GBX	0,00%		+5,71%	-43,08%

01/03	Nuformix kondigt inschrijving aan om GBP150.000 op te halen	AN
15/01	Nuformix plc rapporteert resultaten voor de achttien maanden eindigend op 30 september 2023	CI

Nuformix announces subscription to raise GBP150,000	01/03
Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	15/01
Nuformix narrows annual loss as develops drug assets	03/01
Earnings Flash (NFX.L) NUFORMIX Reports FY23 Loss GBX-0.12	03/01
Nuformix plc Reports Earnings Results for the Half Year Ended September 30, 2023	03/01
Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002	23-10-23
Nuformix Receives Japanese Patent for Pulmonary Fibrosis Treatment; Shares Surge	23-10-23
Nuformix plc Announces Notice of Allowance of NXP002 Patent in Japan	23-10-23
Nuformix to fund its unlicensed programs with NXP001 windfall	05-10-23
Nuformix Updates Oxilio Agreement for NXP001	18-09-23
Nuformix to receive milestone payments from Oxilio pact	18-09-23
Nuformix plc Receives New NXP001 Development Milestone Payments in Updated Oxilio Agreement	18-09-23
Nuformix loss narrows; near-term goal to focus on NXP002 asset	22-05-23
Earnings Flash (NFX.L) NUFORMIX Posts FY23 EPS GBX0.11	22-05-23
Earnings Flash (NFX.L) NUFORMIX Posts Fiscal H1 EPS GBX0.11	22-05-23
Nuformix plc Reports Earnings Results for the Full Year Ended March 31, 2023	22-05-23
Nuformix says NXP002 shows anti-inflammatory effect	18-05-23
Nuformix to Launch Partnering Process for Inhaled Lung Disease Drug	18-05-23
Nuformix plc Announces Update Regarding the NXP002 Programme	18-05-23
FTSE 100 Inches Up as Market Awaits Key Inflation, Earnings Figures	17-04-23

Geen resultaten voor deze zoekopdracht